Fresenius Medical Care AG (FMS)
21.72
+0.84
(+4.00%)
USD |
NYSE |
May 10, 16:00
21.72
0.00 (0.00%)
After-Hours: 20:00
Fresenius Medical Care Free Cash Flow (Quarterly): -7.160M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.160M |
December 31, 2023 | 498.40M |
September 30, 2023 | 676.88M |
June 30, 2023 | 928.78M |
March 31, 2023 | 0.7561M |
December 31, 2022 | 441.16M |
September 30, 2022 | 467.66M |
June 30, 2022 | 617.17M |
March 31, 2022 | -3.803M |
December 31, 2021 | 481.77M |
September 30, 2021 | 566.95M |
June 30, 2021 | 857.81M |
March 31, 2021 | 28.13M |
December 31, 2020 | 237.79M |
September 30, 2020 | 748.56M |
June 30, 2020 | 2.313B |
March 31, 2020 | 333.37M |
December 31, 2019 | 493.17M |
September 30, 2019 | 637.43M |
June 30, 2019 | 626.22M |
March 31, 2019 | -142.32M |
December 31, 2018 | 451.10M |
September 30, 2018 | 562.14M |
June 30, 2018 | 500.19M |
March 31, 2018 | -327.14M |
Date | Value |
---|---|
December 31, 2017 | 200.02M |
September 30, 2017 | 499.28M |
June 30, 2017 | 743.11M |
March 31, 2017 | -29.78M |
December 31, 2016 | 561.12M |
September 30, 2016 | 192.93M |
June 30, 2016 | 424.77M |
March 31, 2016 | -70.45M |
December 31, 2015 | 252.33M |
September 30, 2015 | 346.37M |
June 30, 2015 | 152.20M |
March 31, 2015 | 256.39M |
December 31, 2014 | 361.49M |
September 30, 2014 | 512.20M |
June 30, 2014 | 230.10M |
March 31, 2014 | -87.00M |
December 31, 2013 | 320.66M |
September 30, 2013 | 408.12M |
June 30, 2013 | 335.65M |
March 31, 2013 | 173.25M |
December 31, 2012 | 335.12M |
September 30, 2012 | 326.75M |
June 30, 2012 | 313.22M |
March 31, 2012 | 350.64M |
December 31, 2011 | 337.37M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.160M
Minimum
Mar 2024
2.313B
Maximum
Jun 2020
547.22M
Average
495.78M
Median
Free Cash Flow (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | 0.3701M |
TC BioPharm (Holdings) PLC | -- |
Adaptimmune Therapeutics PLC | -15.50M |
Bicycle Therapeutics PLC | -70.88M |